| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.00025 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00022 | 1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.00017 | 1 |